BACE1 and Alzheimer disease: Reportedly, oxidative damage causes neuroinflammation and mediates BACE-1 activity [42,43], and Aβ produced by BACE-1 can, in turn, lead to ROS production, which further exacerbates the symptoms of AD [8,44,45].